Company: PSTV
Filing Date: 2025-04-04
Form Type: S-3
Source: 0001193125-25-073481
Chunk: 12

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-04-04
Form: S-3
Chunk 12
---
 B Warrants will reset to a price equal to the greater of (i) $0.132
(the “Floor Price”), and (ii) the lowest volume weighted average price during the period commencing on the first trading day immediately following the later of (x) the earlier of (A) the first (1) trading day after the registration statement of which this prospectus forms a part is declared effective, or (B) the first (1) trading
day after the date on which the holder of those securities can sell them pursuant to Rule 144 without restriction or limitation, or (y) the first (1) trading day after the Warrant
Stockholder Approval (as defined below) is obtained, and the number of shares issuable upon exercise will be proportionately adjusted such that the aggregate exercise price will remain unchanged. The Floor Price is subject to appropriate adjustment
for any stock dividend, stock split, stock combination, reclassification or similar transaction.

In the event that the exercise price of the Series A
Warrants and Series B Warrants is reduced to the Floor Price pursuant to the reset provision, the 28,042,138 outstanding Series A Warrants would become exercisable for an aggregate of up to 280,421,380 shares of Common Stock at the Floor Price and
the 28,042,138 outstanding Series B Warrants would become exercisable for an aggregate of up to 420,632,070 shares of Common Stock, or an aggregate of up to 1,261,896,210 shares of Common Stock assuming the Series B Warrants are exercised
pursuant to the zero exercise price provision.

Adjustment for Subsequent Issuances. Subject to certain exceptions, if the Company sells any common
stock (or securities convertible into or exercisable into common stock) at a price per share (or conversion or exercise price, as applicable) less than the exercise price of the Series A Warrants then in effect, then the exercise price of the
Series A Warrants will be reduced to such lower price, but no lower than the Floor Price, and the number of shares issuable upon exercise will be proportionately adjusted such that the aggregate exercise price will remain unchanged.

Share Combination Event Adjustment. If at any time on or after the date of issuance there occurs any share split, share dividend, share combination
recapitalization or other similar transaction involving our common stock and the lowest daily volume weighted average price during the period commencing on the trading day immediately following the applicable date of